COVID-19

Post-COVID-19 immune dysfunction is supported by epidemiological, clinical, and laboratory evidence. Attributing, with little to no evidence, that masking and lack of exposure is the primary driver of increases in bacterial and viral infections discourages critical interventions needed to stop the spread of disease.

The Conference on Retroviruses and Opportunistic Infections 2023 has research in COVID-19, mpox, hepatitis, and other viral infections, plus networking, and even Anthony Fauci, MD, speaking on his legacy.

Catching COVID-19 to prevent a more severe case is not a good strategy, says Kevin Kavanagh, MD.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 17, 2023.

COVID-19 reinfection chances vary to variant and time since the previous infection, according to a new study.

What can the media do to better cover the "tripledemic," and where are all the advocacy groups for these infectious diseases?

The triple epidemic or “tripledemic” of influenza, COVID-19, and respiratory syncytial virus (RSV) may have peaked. What caused the confluence of these viruses to start, and how can we stop it from happening again?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 10, 2023.

Can a patient catch C difficile if the previous hospital room occupant had it?

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending February 3, 2023.

Could live attenuated vaccines and intranasal vaccines be the answer for RSV, COVID-19, and even cancer tumors?

How can food service and health care workers prevent the spread of norovirus? Keeping employees at home, using the correct products the right way, and more.

Are norovirus cases going to skyrocket, or will the pandemic slowdown of this infectious disease continue?

The FDA's Vaccines and Related Biological Products Advisory Committee laid out a simpler direction for SARS-CoV-2 development and deployment.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 27, 2023.

Saskia v. Popescu, PhD, MPH, MA, CIC, discusses the latest in COVID-19, a CDC shake-up, and the bird flu.

Infection Control Today's® Product Locator is a monthly column highlighting some of the latest advanced technology in the infection prevention field.

Kevin Kavanagh, MD, examines the current bird flu outbreak and the possible dangers it holds for humans.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 20, 2023.

Moderna announced encouraging news about its RSV mRNA-1345 vaccine and plans to submit for regulatory approval in the first half of 2023.

Information for infection preventionists to manage ESBL-producers even while fighting against COVID-19.

Kevin Kavanagh, MD, explains his concern about immunodysfunction and the possibility of its effects on hospitals.

New study shows home infusion therapy staff may have significant barriers to infection-surveillance training, and this could be leading to higher infection rates.

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending January 13, 2023.

How do infection preventionists navigate the many—and often contradictory—requirements that fighting the COVID-19 pandemic has brought upon them?